| Jul 31 |
IDEAYA in license agreement with Biocytogen for antibody drug conjugate program
|
| Jul 31 |
Biocytogen Announces Option and License Agreement with IDEAYA Biosciences for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program
|
| Jul 31 |
IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen
|
| Jul 29 |
IDEAYA Biosciences to Participate in Upcoming August 2024 Investor Relations Event
|
| Jul 23 |
How Much Upside is Left in IDEAYA Biosciences (IDYA)? Wall Street Analysts Think 32.97%
|
| Jul 15 |
Industry Analysts Just Made A Meaningful Upgrade To Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Revenue Forecasts
|
| Jul 11 |
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
|
| Jul 11 |
Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure
|
| Jul 10 |
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
| Jul 10 |
Biggest stock movers today: BIDU, LZ, and more
|
